Moors & Cabot’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11,000
Closed -$259K 745
2020
Q3
$259K Hold
11,000
0.02% 510
2020
Q2
$268K Buy
11,000
+2,000
+22% +$49.4K 0.03% 476
2020
Q1
$231K Buy
+9,000
New +$214K 0.03% 458
2019
Q2
Sell
-19,000
Closed -$411K 556
2019
Q1
$411K Buy
+19,000
New +$404K 0.06% 316

Other funds holding BTAL

Moors & Cabot's BTAL Position: Q4 2020 in Review

Moors & Cabot sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2020, closing a stake of 11,000 shares — an estimated $259K sold.

Moors & Cabot first reported a position in BTAL in Q1 2019 and held it in 4 quarters. The position peaked at $411K in Q1 2019. 36 funds tracked by Wall St. Rank hold BTAL as of Q4 2020.

  • Moors & Cabot reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2020 after selling out during the quarter.
  • Moors & Cabot sold 11,000 AGF US Market Neutral Anti-Beta Fund shares in Q4 2020, an estimated $259K.
  • Moors & Cabot first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2019 and held it in 4 quarters.
  • Moors & Cabot's AGF US Market Neutral Anti-Beta Fund position peaked at $411K in Q1 2019.
  • 36 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2020.

Based on Moors & Cabot's 13F filing for Q4 2020, filed 11 Feb 2021.